Alivus Life Sciences Shows Strong Momentum with Consecutive Gains and Outperformance

Alivus Life Sciences has shown significant activity today, gaining 5.35% on March 20, 2025. The stock has outperformed its sector by 4.4%, marking a notable trend as it has experienced consecutive gains over the past three days, accumulating a total return of 10.15% during this period. The stock reached an intraday high of Rs 1133.5.
In terms of moving averages, Alivus Life Sciences is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward momentum. Over the past week, the stock has delivered an 8.83% return, significantly surpassing the Sensex's 3.35% performance.

Looking at longer-term metrics, Alivus Life Sciences has achieved a remarkable 51.00% increase over the past year, compared to the Sensex's 5.82%. Year-to-date, the stock has risen by 13.34%, while the Sensex has declined by 2.35%. Over the last three years, Alivus Life Sciences has delivered an impressive 142.88% return, significantly outpacing the Sensex's 31.86%.